Table of Contents

company-logo

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.

Viridian Therapeutics Dividend Announcement

• Viridian Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Viridian Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Viridian Therapeutics Dividend History

Viridian Therapeutics Dividend Yield

Viridian Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Viridian Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Viridian Therapeutics Financial Ratios

P/E ratio-7.20
PEG ratio-7.41
P/B ratio3.10
ROE-49.65%
Payout ratio0.00%
Current ratio15.82
Quick ratio15.82
Cash Ratio2.93

Viridian Therapeutics Dividend FAQ

Does Viridian Therapeutics stock pay dividends?
Viridian Therapeutics does not currently pay dividends to its shareholders.
Has Viridian Therapeutics ever paid a dividend?
No, Viridian Therapeutics has no a history of paying dividends to its shareholders. Viridian Therapeutics is not known for its dividend payments.
Why doesn't Viridian Therapeutics pay dividends?
There are several potential reasons why Viridian Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Viridian Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Viridian Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Viridian Therapeutics a dividend aristocrat?
Viridian Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Viridian Therapeutics a dividend king?
Viridian Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Viridian Therapeutics a dividend stock?
No, Viridian Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Viridian Therapeutics stocks?
To buy Viridian Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Viridian Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.